Literature DB >> 20378166

The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Erin G Rosenbaugh1, James W Roat, Lie Gao, Rui-Fang Yang, Devika S Manickam, Jing-Xiang Yin, Harold D Schultz, Tatiana K Bronich, Elena V Batrakova, Alexander V Kabanov, Irving H Zucker, Matthew C Zimmerman.   

Abstract

Adenoviral-mediated overexpression of the intracellular superoxide (O(2)(*-)) scavenging enzyme copper/zinc superoxide dismutase (CuZnSOD) in the brain attenuates central angiotensin II (AngII)-induced cardiovascular responses. However, the therapeutic potential for adenoviral vectors is weakened by toxicity and the inability of adenoviral vectors to target the brain following peripheral administration. Therefore, we developed a non-viral delivery system in which CuZnSOD protein is electrostatically bound to a synthetic poly(ethyleneimine)-poly(ethyleneglycol) (PEI-PEG) polymer to form a polyion complex (CuZnSOD nanozyme). We hypothesized that PEI-PEG polymer increases transport of functional CuZnSOD to neurons, which inhibits AngII intra-neuronal signaling. The AngII-induced increase in O(2)(*-), as measured by dihydroethidium fluorescence and electron paramagnetic resonance spectroscopy, was significantly inhibited in CuZnSOD nanozyme-treated neurons compared to free CuZnSOD- and non-treated neurons. CuZnSOD nanozyme also attenuated the AngII-induced inhibition of K(+) current in neurons. Intracarotid injection of CuZnSOD nanozyme into rabbits significantly inhibited the pressor response of intracerebroventricular-delivered AngII; however, intracarotid injection of free CuZnSOD or PEI-PEG polymer alone failed to inhibit this response. Importantly, neither the PEI-PEG polymer alone nor the CuZnSOD nanozyme induced neuronal toxicity. These findings indicate that CuZnSOD nanozyme inhibits AngII intra-neuronal signaling in vitro and in vivo. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378166      PMCID: PMC2860066          DOI: 10.1016/j.biomaterials.2010.03.026

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  41 in total

1.  Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats.

Authors:  K Yoshida; G F Burton; J S McKinney; H Young; E F Ellis
Journal:  Stroke       Date:  1992-06       Impact factor: 7.914

2.  Whole cell patch recordings from forebrain slices demonstrate angiotensin II inhibits potassium currents in subfornical organ neurons.

Authors:  A V Ferguson; Z Li
Journal:  Regul Pept       Date:  1996-10-08

3.  Tissue distribution of 125I-labelled bovine superoxide dismutase (SOD) in the rat.

Authors:  B Odlind; L E Appelgren; A Bayati; M Wolgast
Journal:  Pharmacol Toxicol       Date:  1988-02

4.  Angiotensin II decreases neuronal delayed rectifier potassium current: role of calcium/calmodulin-dependent protein kinase II.

Authors:  M Zhu; C H Gelband; P Posner; C Sumners
Journal:  J Neurophysiol       Date:  1999-09       Impact factor: 2.714

5.  Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.

Authors:  Ken Kazama; Josef Anrather; Ping Zhou; Helene Girouard; Kelly Frys; Teresa A Milner; Costantino Iadecola
Journal:  Circ Res       Date:  2004-10-21       Impact factor: 17.367

6.  Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells.

Authors:  Matthew C Zimmerman; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

7.  Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Ram V Sharma; Robin L Davisson
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

8.  Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain.

Authors:  Matthew C Zimmerman; Ryan P Dunlay; Eric Lazartigues; Yulong Zhang; Ram V Sharma; John F Engelhardt; Robin L Davisson
Journal:  Circ Res       Date:  2004-07-22       Impact factor: 17.367

9.  Subfornical organ: forebrain site of pressor and dipsogenic action of angiotensin II.

Authors:  M L Mangiapane; J B Simpson
Journal:  Am J Physiol       Date:  1980-11

10.  Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance.

Authors:  J S Beckman; R L Minor; C W White; J E Repine; G M Rosen; B A Freeman
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

View more
  29 in total

Review 1.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  PECAM-targeted delivery of SOD inhibits endothelial inflammatory response.

Authors:  Vladimir V Shuvaev; Jingyan Han; Kevin J Yu; Shaohui Huang; Brian J Hawkins; Muniswamy Madesh; Marian Nakada; Vladimir R Muzykantov
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

Review 4.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

5.  Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.

Authors:  Jing Tong; Matthew C Zimmerman; Shumin Li; Xiang Yi; Robert Luxenhofer; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2011-02-20       Impact factor: 12.479

6.  Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo.

Authors:  Jing Tong; Xiang Yi; Robert Luxenhofer; William A Banks; Rainer Jordan; Matthew C Zimmerman; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2012-12-17       Impact factor: 4.939

Review 7.  Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart.

Authors:  Chengju Tian; Fadhel Alomar; Caronda J Moore; Chun Hong Shao; Shelby Kutty; Jaipaul Singh; Keshore R Bidasee
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 8.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

9.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

10.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Authors:  Devika S Manickam; Anna M Brynskikh; Jennifer L Kopanic; Paul L Sorgen; Natalia L Klyachko; Elena V Batrakova; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.